
Extended Fertility Results for Previous Depo-Provera Users
Clarifying misunderstandings about Depo-Provera's long-term effects on reproductive health and how it affects fertility following discontinuation
Monday, November 25, 2024 - With up to three months of pregnancy prevention per dose, the injectable contraceptive Depo-Provera is known for its simplicity and potency. Still, consumers and healthcare professionals have long debated concerns about how it affects fertility following withdrawal. Although Depo-Provera does not induce permanent infertility, its special impact on ovulation and menstrual cycles can affect the speed with which fertility recovers once a user stops the injections. Experienced national Depo Provera brain injury attorneys have successfully developed Depo-Provera litigation against the manufacturers of the drug. The World Health Organization (WHO) estimates that most Depo-Provera users should anticipate their fertility to return one year following their last injection. Studies reveal, nonetheless, that the timing varies and some people have delays of up to 18 months before their ovulation cycles regulate. "Depo-Provera suppresses ovulation for as long as the hormone stays active in the body," says Johns Hopkins University gynecological professor Dr. Anne Burke. " Not permanent impairment to reproductive health, but rather the slow clearance of the medicine accounts for the longer period of time for fertility restoration.
According to a 2021 Contraception article, 50% of former Depo-Provera users were able to conceive within 10 months of stopping the medication, while over 80% conceived within 18 months. After similar periods of withdrawal, these rates are on par with fertility results for users of alternative hormonal contraceptives such as oral contraceptive pills and implants. The age of the user is one element affecting fertility recovery. Because of increased baseline ovarian reserves and hormonal activity, ovulation often starts faster in younger people. Older people nearing the end of their reproductive years, on the other hand, may naturally have falling fertility, which would aggravate the effects of Depo-Provera's delayed ovulation. Still, another factor is the length of Depo-Provera use. Although there is no data showing that long-term use permanently reduces fertility, certain studies show that those who injected the injection several years ago may have somewhat longer delays in the resuming of ovulation than those who used it temporarily. This is ascribed to the hormonal action on the hypothalamic-pituitary-ovarian axis controlling menstrual periods.
Offering straightforward, evidence-based information during contraceptive counseling, public health campaigns and healthcare practitioners regularly answer questions concerning fertility outcomes. Many stress that Depo-Provera is only a temporary contraceptive choice and most users will be able to conceive within a reasonable period. For those with time-sensitive family planning goals especially, counseling emphasizes the need for planning for fertility return upon stopping the injection. Healthcare professionals may advise treatments to help control ovulation for those who suffer protracted delays in fertility recovery. Along with medical alternatives include ovulation-inducing drugs, these can include lifestyle changes including keeping a good weight and lowering stress. Still, most users automatically regain ovulation with time, hence such treatments are rarely required. There are misunderstandings regarding how Depo-Provera affects long-term fertility, especially in areas where access to proper reproductive health knowledge is restricted. Public health efforts stressing the transient effects of the medicine help to dispel these misconceptions Planned Parenthood and the Guttmacher Institute are among the groups that offer tools to handle shared issues, therefore enabling people to make wise choices regarding their use of contraceptives and future family planning.
More Recent Depo Provera Lawsuit News:
- Post-Depo-Provera Bone Loss Often Unmonitored by Doctors | 7/6/2025
- Depo-Provera Advertising Criticized for Downplaying Health Risks | 7/6/2025
- Conflicting Medical Advice About Depo-Provera Frustrates Users | 7/6/2025
- Distress Is Caused by Physical Appearance Changes From Depo-Provera | 7/3/2025
- Medical Clarity Is Lacking in Depo-Provera Hormonal Imbalance Recovery | 7/3/2025
- Refusal of Insurance to Treat Depo-Provera Complications | 7/3/2025
- Depo-Provera Users Claim They Were Pressured to Continue Despite Side Effects | 7/1/2025
- Unpredictable Bleeding Patterns Following Depo-Provera Injections | 7/1/2025
- Depo-Provera Mood Side Effects Frequently Dismissed by Providers | 7/1/2025
- Lack Of Informed Consent Prior To First Depo-Provera Injection | 6/30/2025
- Depo-Provera Users Are Not Warned About Long-Term Fertility Delays | 6/30/2025
- Depo-Provera Side Effects Persist Despite Multiple Doctor Visits | 6/30/2025
- How Depo-Provera And Mood Stabilizers Work Together In People With Bipolar Disorder | 6/12/2025
- 2025 Policy Changes for Using Depo-Provera in Correctional Health Systems | 6/12/2025
- Insurance Coding Confusion Around Depo-Provera Administration Fees | 6/12/2025
- Breastfeeding And Milk Volume After Using Depo-Provera | 6/11/2025
- A Comparison Of The Time It Takes To Get Pregnant Again After Depo And Implants | 6/11/2025
- AI-Based Detection of Adverse Events in Depo-Provera Surveillance Data | 6/11/2025
- Changes To Medicaid Formularies And Access To Depo-Provera In Rural Clinics | 6/9/2025
- Depo-Provera And Its Role In Stopping Violence Against Women | 6/9/2025
- Review of Injectable Contraceptives and Cervical Health by the WHO Task Force 2025 | 6/9/2025
- Prescribing Depo-Provera For Women Military Veterans | 6/8/2025
- How Depo-Provera Affects Iron Levels and the Risk of Anemia | 6/8/2025
- FDA Monitoring of Depo-Provera in Postmarketing Safety Reports For 2025 | 6/8/2025
- Guidelines of New Medical Association Discourage Depo-Provera Use Among Women Having Family Strokes | 5/12/2025
- Telehealth Providers Under Fire For Prescription Depo-Provera Without In-Person Review | 5/12/2025
- Legal Action Alleging Non-English Speakers Not Warned About Depo-Provera Risks | 5/12/2025
- Depo-Provera Use and Reproductive Autonomy in Immigrant Communities | 5/11/2025
- Digital Health Apps Alert Users to the Potential Cycle Disruption Effects of Depo-Provera | 5/11/2025
- A New NIH Grant to Examine the Effects of Depo-Provera on Brain Plasticity | 5/11/2025
- CDC Survey Findings on Changes in Depo-Provera Use Among Teens | 5/8/2025
- Recent Congressional Hearing on Hormonal Contraception Pharmaceutical Liability | 5/8/2025
- Trends in Male Contraceptive Research Demand Review of Female Injectable Alternatives | 5/8/2025
- Effect Of Depo-Provera On Female COVID-19 Vaccine Efficacy | 5/7/2025
- FDA Examining Labeling Accuracy For Users Of Long-Term Depo-Provera | 5/7/2025
- New WHO Review of Depo-Provera Included In World Contraceptive Guidelines | 5/7/2025
- Insurance Variations in Coverage for Conditions Linked to Depo-Provera | 4/17/2025
- Timeline For Hormonal Balance After Quitting Depo-Provera Including Post-Use Recovery | 4/17/2025
- Ethical Issues Regarding Depo-Provera Use in Programs for International Development and Aid | 4/17/2025
- Environmental Issues With Water Systems Depo-Provera Waste | 4/16/2025
- Potential Link Between Depo-Provera and Lupus Flares in Diagnosed Patients | 4/16/2025
- Comparing The Side Effects of Depo-Provera in Smokers and Non-Smokers | 4/16/2025
- Neurological Testing Errors in Clinical Trials Aimed at Depo-Provera Approval | 4/15/2025
- Special Risks And Considerations Of Using Depo-Provera In Women Over Forty | 4/15/2025
- Effects Of Depo-Provera On Oral Health Gum Disease And Tooth Loss | 4/15/2025
- Relationship Between Early Onset Perimenopause Symptoms And Depo-Provera | 4/13/2025
- Use of Depo-Provera Among Women Having a Family History of Hormone-responsive cancers | 4/13/2025
- The Effect Of Depo-Provera On Mammogram Clarity And Breast Tissue Density | 4/13/2025
- Legal And Ethical Questions Related To Forced Depo-Provera Use In Vulnerable Populations | 3/23/2025
- Impact Of Depo-Provera On Skin Elasticity And Aging | 3/23/2025
- Depo-Provera's Use in the Management of Polycystic Ovary Syndrome | 3/23/2025
- Investigating Whether The Use Of Depo-Provera Changes Gut Bacteria And What This Means For Digestion | 3/18/2025
- Examining Whether Hormonal Changes From Depo-Provera Use May Help To Explain Ocular Health Problems | 3/18/2025
- Evaluating Reports That Depo-Provera May Cause Insomnia, Night Sweats, or Disturbed Sleep Cycles | 3/18/2025
- Analyzing Whether Depo-Provera Has Been Prescribed Off-Label for Transgender People And Its Effects On Hormone Levels | 3/17/2025
- Investigating Depo-provera affects on liver enzymes and liver health in long-term users | 3/17/2025
- Examining Whether Long-Term Depo-Provera Use Affects General Health By Lowering Vitamin D Levels | 3/17/2025
- Long-Term Bone Health Risk: Depo-Provera | 3/16/2025
- New Lawsuits Against Pfizer over Depo-Provera | 3/16/2025
- Depo-Provera and Cognitive Decline | 3/16/2025
- Depo-Provera And Links To Higher Blood Clot Risk | 2/23/2025
- Depo-Provera Could Cause High Blood Pressure Over Time | 2/23/2025
- Some Blame Fluid Retention And Swollen Extremities On Depo-Provera | 2/23/2025
- Depo-Provera And Skin Pigment Changes Called Melasma | 2/20/2025
- Depo-Provera May Increase Recurrent Urinary Tract Infection Risk | 2/20/2025
- Depo-Provera Patients Report Joint Pain And Muscle Aches | 2/20/2025
- Depo-Provera Might Raise Allergic Reactions' Risk And Cause Skin Rashes | 2/20/2025
- Depo-Provera Might Affect The Digestive System Causing Bloating and Nausea | 2/20/2025
- Depo-Provera Could Lead to Regular Migraines | 2/20/2025
- Depo-Provera Lessens Libido and Interest in Intimacy | 2/18/2025
- Sometimes Excess Facial and Body Hair Growth Is Related to Depo-Provera | 2/18/2025
- Depo-Provera Might Cause Noticeable Hair Loss and Thinning | 2/18/2025
- Depo-Provera Seems To Throw Off Typical Menstrual Cycle | 2/17/2025
- Depo-Provera Can Make Mood Swings And Anxiety Worse | 2/17/2025
- Depo-Provera Tends To Cause Unwanted Weight Gain | 2/17/2025
- Allegation of Deceptive Advertising Strategies by Minimizing the Depo-Provera Potential Risks | 1/28/2025
- Claims About Misrepresentation Of How Quickly Fertility Is Restored After Stopping Depo-Provera | 1/28/2025
- Plaintiffs Claimed Emotional Stress Resulting From Untreated Side Effects Of Depo-Provera | 1/28/2025
- Delayed Side Effects of Prolonged Patient Suffering Linked to Depo-Provera | 1/27/2025
- Insufficient Risk Awareness In Depo-Provera Counseling | 1/27/2025
- Inadequate Training Of Healthcare Providers: Insufficient Risk Awareness In Depo-Provera Counseling | 1/27/2025
- Legal Action Concerns Regarding Safety Profile of Depo-Provera | 1/27/2025
- Bone Density Loss: Concerns About Long-Term Depo-Provera Use | 1/25/2025
- Consolidating Depo-Provera Lawsuits For Efficiency: Multidistrict Litigation, or MDL | 1/25/2025
- Class-Action Lawsuits Alleging Harm From Depo-Provera | 1/25/2025
- Revised Depo-Provera's Labeling In Europe To Alert About The Risk Of Meningiomas | 1/22/2025
- A Lack Of Disclosure Of The Potential Risks Associated With Depo-Provera, Including The Development Of Brain Tumors | 1/22/2025
- Studies Have Linked Depo-Provera To A Higher Risk Of Developing Meningiomas Fueling Lawsuits Against Pfizer | 1/22/2025
- Secondary Cancer Risks From Extended Contraceptive Use | 1/21/2025
- Inappropriate Off-Label Depo-Provera Use | 1/21/2025
- A Patient Developed Migraines Linked To Depo-Provera Use | 1/21/2025
- Inadequate Depo-Provera Risk Training of Healthcare Providers | 1/20/2025
- Alleged Emotional Stress Due To Undiagnosed Depo-Provera Side Effects | 1/20/2025
- Mislabeling Of Risks Associated With Depo-Provera | 1/20/2025
- The Connection Between Endocrine Problems and Depo-Provera | 1/19/2025
- Emphasizing Patient Safety and Correct Contraceptive Use Risk Factors | 1/19/2025
- Pharmaceutical Industry Negligence Punishment Policies | 1/19/2025
- Questioning Patient Safety And Informed Consent | 1/17/2025
- Medical Responsibility For Follow-Up Care For Depo-Provera Patients | 1/17/2025
- National Awareness Of The Dangers Connected With The Off-Label Use of Depo-Provera | 1/17/2025
- Deceptive Depo-Provera Advertising Practices Alleged | 1/16/2025
- The Lack of Informed Consent in Administering Depo-Provera to Adolescents | 1/16/2025
- Prolonged Depo-Provera Use-Based Delayed Diagnosis Of Brain Tumors | 1/16/2025
- Medical Malpractice For Prescribing Depo-Provera Without The Appropriate Patient History | 1/14/2025
- Misrepresentation Of Long-Term Fertility Restoration After Discontinuation Depo-Provera | 1/14/2025
- Alleged Inadequate Warning Labels For Depo-Provera Regarding Meningioma Risks | 1/14/2025
- Managing Neurological Conditions Related to Depo-Provera | 12/29/2024
- Effect of Patient Education Regarding Early Depo Provera-Related Brain Tumors | 12/29/2024
- Comparative Investigation of Several Hormonal Contraceptives Including Depo-Provera on Brain Function | 12/29/2024
- Dietary Strategies to Support Brain Function in Depo-Provera Users | 12/26/2024
- Menopause Transition and Brain Tumor Risk in Long-Term Depo-Provera Users | 12/26/2024
- Headache Differential Diagnosis in Meningioma Users of Depo-Provera | 12/26/2024
- Depo-Provera's Affect on Rates of Brain Tumor-Related Death | 12/24/2024
- Guidelines for Safer Contraceptive Use in Individuals at Meningioma Risk | 12/24/2024
- Developments in Biomarkers for Brain Tumors Induced by Depo-Provera | 12/24/2024
- Endocrinologist Role in Controlling Hormonal Abnormalities in Brain Tumor Patients | 12/22/2024
- The Economics of Depo-Provera Related Brain Tumor Treatments | 12/22/2024
- Public Health Approaches to Reduce Brain Tumor Risk among Users of Contraceptives | 12/22/2024
- Support of Brain Tumor Screenings for Women Prescribed Depo-Provera | 12/21/2024
- Long-Term Effects on Mental Health of Depo-Provera Brain Tumors | 12/21/2024
- Comparing Tumor Growth Rates Between Depo-Provera Users and Non-Users | 12/21/2024
- Hormone-Sensitive Tumor Treatments for Meningiomas Linked to Depo-Provera | 12/19/2024
- Secondary Cancer Risk Following Depo-Provera-Induced Brain Tumors | 12/19/2024
- Decline of Blood-Brain Barrier Integrity Under Depo-Provera | 12/19/2024
- Asymptomatic Meningiomas Common in Long-Term Depo-Provera Users | 12/19/2024
- Investigating Genetic Modifications in Brain Tumors Associated With Depo-Provera | 12/19/2024
- Evaluating Genetic Markers for Brain Tumor Susceptibility Among Users of Depo-Provera | 12/19/2024
- Possible Cognitive Effects of Depo-Provera in Individuals Affected by Brain Tumors | 12/18/2024
- Use Depo-Provera During Adolescence and Effects on Long-Term Brain Development | 12/18/2024
- Neurologists Role in Monitoring Brain Tumor Symptoms in Depo-Provera Users | 12/18/2024
- Meningioma Histological Variations Linked to Depo-Provera Use | 12/16/2024
- Medical Control of Brain Tumors in Depo-Provera Users | 12/16/2024
- Links Between Meningioma Recurrence in Users of Depo-Provera and Progesterone Therapy | 12/16/2024
- Outcomes Following Treatment for Depo-Provera Users Diagnosed with Meningiomas | 12/15/2024
- MRI and CT Scans Identify Meningiomas Linked to Depo-Provera | 12/15/2024
- Depo-Provera Discontinuation Effects Brain Tumor Progression | 12/15/2024
- Tracking Depo-Proveras Effects on Metabolic Health and Weight Over Time | 11/28/2024
- Global Variations in Depo-Provera Use Policies and Guidelines | 11/28/2024
- Migraines with Depo-Provera - Evaluating the Connection | 11/28/2024
- Researching Potential Effects of Depo-Provera on Thyroid Health | 11/26/2024
- The Part Pharmaceutical Transparency Plays in Depo-Provera Health Risks | 11/26/2024
- Correcting Myths and Misinformation About Depo-Provera Use | 11/26/2024
- How Public Health Initiatives Handle the Side Effects from Depo-Provera Contraception | 11/25/2024
- The Ethical Argument Regarding Informed Consent for Depo-Provera Clinical Settings | 11/25/2024
- Depo-Provera's Historical Evolution and Trials | 11/24/2024
- Contrasting Side Effects of Depo-Provera With Other Progestin-Only Controllers | 11/24/2024
- Depo-Provera's Cultural Effects on Low-Income and Minority Communities | 11/24/2024
- Effects of Discontinuation on Physical And Mental Health For Users of Depo-Provera | 11/21/2024
- Use and Risks of Depo-Provera as Emergency Contraception | 11/21/2024
- Possible Effects of Depo-Provera on Autoimmune Diseases | 11/21/2024
- Evaluating the Popularity of Depo-Provera Among Medical Professionals | 11/19/2024
- Examining Gender Roles in Contraceptive Litigation | 11/19/2024
- Examining Gender Roles in Contraceptive Litigation | 11/19/2024
- The Function of Patient Support Groups Regarding Health Issues Related to Depo-Provera | 11/19/2024
- Emotional Health Effects Over Long Terms for Depo-Provera Users | 11/18/2024
- Recognizing Variations Between Depo-Provera and Depo-SubQ Provera | 11/18/2024
- The Part Patient Education Plays in Depo-Provera Contraceptive Choices | 11/18/2024
- How Lifestyle Choices Influence Side Effects from Depo-Provera | 11/17/2024
- Investigating Bone Density Loss in Relation to Depo-Provera | 11/17/2024
- Risk Factors for Hormone-Related Side Effects in Users of Depo-Provera | 11/17/2024
- Ethical Consequences of Pharmaceutical Marketing for Developing Nations Depo-Provera | 11/16/2024
- Menopause with Depo-Provera Effects on Older Users of the Injection | 11/16/2024
- Regulatory Agencies' Impact on Depo-Provera Approval Background | 11/16/2024
- Beyond Hormonal Injections: Alternative Contraceptives | 11/13/2024
- Social Media Advocacy's Part in Depo-Provera Health Awareness | 11/13/2024
- Long-Term Contraceptive Safety - Comparatively Evaluating Depo-Provera and IUD | 11/13/2024
- Long-Term Contraceptive Safety - Comparatively Evaluating Depo-Provera and IUD | 11/13/2024
- Psychological consequences of a meningioma diagnosis for users of Depo-Provera | 10/28/2024
- Clinical Trials Part in Verifying Depo-Provera's Meningioma Link | 10/28/2024
- Legal Rights of Depo Provera Users In Multi District Litigation | 10/28/2024
- Future Directions in Contraceptive Lawsuits Outside of Depo-Provera | 10/28/2024
- Social Media Impact on Public Opinion of Depo-Provera Lawsuits | 10/28/2024
- How Insurance Companies Handle Meningioma Depo-Provera Claims | 10/27/2024
- Non-Hormonal Contraceptives for Women Concerned About Meningioma | 10/27/2024
- The Place of Class Certification in Depo-Provera Meningioma Lawsuits | 10/27/2024
- Best Practices for Expert Testimony in Depo-Provera Meningioma Lawsuits | 10/27/2024
- The Moral Conundrums of Pharmaceutical Marketing and Depo-Provera Side Effects | 10/24/2024
- How International Courts Treat Meningioma Claims Made Depo Provera | 10/24/2024
- Comparative Analysis of Depo-Provera Meningioma Lawsuits In U.S. and European Cases | 10/24/2024
- The Financial Burden Depo-Provera-Related Meningioma Treatments Entail | 10/21/2024
- How Doctors Handle Meningioma Risk in Prescriptions for Depo-Provera | 10/21/2024
- The Effect Early Diagnosis Has on Depo-Provera Meningioma Legal Settlements | 10/21/2024
- The Part Genetic Factors Play in Depo-Provera Meningioma Cases | 10/21/2024
- Meningioma Medical Screening for Depo-Provera Users | 10/21/2024
- Evaluating Meningioma Lawsuits from Depo-Provera against Other Contraceptive Litigation | 10/20/2024
- How DepoProvera Meningioma Victim Families Can Pursue Legal Action | 10/20/2024
- Worldwide Trends In DepoProvera Meningioma Litigation | 10/20/2024
- Examining DepoProvera s Effects on Brain Function Beyond Meningioma | 10/20/2024
- Law firms handling of depo provera meningioma cases | 10/20/2024
- Government Oversight of Depo-Provera Safety | 10/17/2024
- Programs for Medical Monitoring Depo-Provera Users Through Regular Check-ups | 10/17/2024
- Contraceptive Safety Evolution Relating To Depo-Provera Lawsuits | 10/17/2024
- How Users of Depo-Provera Might Guard Against Meningioma Risk | 10/17/2024
- Significant Compensation May Be Available To Victims of Meningioma Related to Depo Provera | 10/17/2024
- Patient Advocacy Roles in Depo-Provera Meningioma Cases | 10/15/2024
- How Depo-Provera Lawsuits Affect Drug Company Policies | 10/15/2024
- Emphasizing Meningioma As A Long Term Health Risk of Using Depo-Provera | 10/15/2024
- Recall of Depo Provera and Its Effect on Meningioma Lawsuits | 9/26/2024
- Anticipated Results In Depo Provera Meningioma Settlements | 9/26/2024
- Selecting a Lawyer for Depo-Provera Meningioma Litigation | 9/26/2024
- Patient Rights in the Depo Provera Meningioma Lawsuits | 9/26/2024
- Long Term Consequences for Meningioma Health in Users of Depo Provera | 9/26/2024
- Recall of Depo Provera and Its Effect on Meningioma Lawsuits | 9/26/2024
- Depo Provera Meningioma Signs and Symptoms | 9/26/2024
- Statute of Limitations for Meningioma Claims Depo-Provera | 9/24/2024
- Multi-District Litigation for Meningioma Cases Depo Provera | 9/24/2024
- Depo Provera Meningioma Lawsuits Changing Contraceptive Safety | 9/24/2024
- Medical Records Importance in Depo Provera Meningioma Lawsuits | 9/24/2024
- Litigation Strategies in Meningioma Cases from Depo Provera | 9/24/2024
- How Pharmaceutical Companies Defend Depo Provera Meningioma Claims | 9/23/2024
- Legal Ramifications For Meningioma Cases Regarding FDA Warnings About Depo Provera | 9/23/2024
- Proving Causation in Depo Provera Meningioma Lawsuits | 9/23/2024
- Meningioma Diagnosis Affects Results of Depo Provera Lawsuits | 9/23/2024
- Meningioma As A Possible Side Effect Of Depo Provera | 9/23/2024
- What Consumers Need to Know About Depo Provera Meningioma Lawsuits | 9/22/2024
- Research Links Meningioma Development with Depo Provera | 9/22/2024
- Financial Compensation And Depo Provera Meningioma Settlements | 9/22/2024
- The Part Hormonal Controllers Play in Meningioma Growth | 9/22/2024
- Legal Interpretive Guidelines for Depo Provera Meningioma Litigation | 9/22/2024
- The Function of Informed Consent Regarding Depo Provera Meningioma Lawsuits | 9/21/2024
- Pharmaceutical Responsibility in Meningioma Cases from Depo Provera | 9/21/2024
- Expert Witnesses Place in Depo Provera Meningioma Lawsuits | 9/21/2024
- Important Information for Plaintiffs Regarding Meningioma Risk with Depo-Provera | 9/20/2024
- Class Action Against Individual Lawsuits in Meningioma Depo Provera Cases | 9/20/2024
- How to Sue Over Meningiomas Linked to Using Depo Provera | 9/20/2024
- Modern Developments in Depo-Provera Meningioma Lawsuits | 9/20/2024
- Important Information for Plaintiffs About The Meningioma Risk With Depo Provera | 9/20/2024
- Legal Resources for Women Affected by Meningiomas and Depo Provera | 9/20/2024
- Making Sense of Meningioma with Depo Provera Use | 9/20/2024
Depo Provera Brain Tumor Attorneys Handling Claims Nationwide
We will represent all persons involved in a Depo Provera lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who has been treated for a meningioma brain tumor and has a history of using Depo Provera for at least a year--or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Depo Provera meningioma lawyers will contact you promptly to discuss your case.